Meningococcal Disease Which adults need meningococcal vaccine? Adults need to be vaccinated if they are at increased risk of meningococcal disease. This includes college students, military personnel, international travelers to areas where meningococcal disease is endemic, scientists who may be exposed to meningococcal bacteria, and those without a functioning spleen. Adults who got the vaccine as adolescents may not need to be vaccinated again. There are two types of meningococcal vaccines currently approved for use in the US. The quadrivalent vaccine protects against four meningococcal serogroups (A, C, W, and Y) and is recommended for routine use in adolescents. The other vaccine protects against serogoup B disease. Adolescents and young adults age 1. B vaccination. Did you know.. Why vaccinate adults against meningococcal disease? Approximately one in 1. Up to 2. 0 percent of those who survive will suffer serious and permanent complications including brain damage, hearing loss, kidney damage, and limb amputations. The early symptoms of infection might be mild and similar to less severe infections, like the flu, which can lead to missed diagnosis. It may start like a bad cold or the flu causing fever, headache, body aches, and a stiff neck, but it can progress very quickly and kill an otherwise healthy person in less than 4. Additional symptoms may include nausea, vomiting, confusion, sensitivity to light, and a dark purple rash on the arms, legs, and body. The bacteria can spread through your body very quickly, affecting arms, legs, fingers, toes, and organs. Why are meningococcal vaccines important? Meningococcal vaccines can greatly reduce or eliminate the risk of getting certain types of meningococcal disease. FAQ: How do you get meningococcal disease? The disease is spread by close, direct contact with people who carry the bacteria in their nose or throat. Some people may just be carriers and will never show symptoms or experience the disease themselves, but they can still spread it. Meningococcal Vaccination for Preteens and Teens . All 1. 1 to 1. 2 year olds should be vaccinated with a single dose of a quadrivalent (protects against serogroups A, C, W, and Y) meningococcal conjugate vaccine. Since protection decreases over time, a booster dose is recommended at age 1. Teens and young adults (1. B meningococcal vaccine (2 or 3 doses depending on brand), preferably at 1. Although meningococcal disease is uncommon, teens and young adults 1. National Meningococcal C Vaccination Program For CowsMeningococcal bacteria can cause severe disease, including infections of the lining of the brain and spinal cord (meningitis) and bloodstream infections (bacteremia or septicemia), and can result in permanent disabilities and even death. Q: Is there one meningococcal vaccine that can help protect my child from all common serogroups (strains) of meningococcal disease? A: No. Some meningococcal vaccines for preteens and teens are designed to protect against four serogroups (A, C, W, and Y), while others help protect against one serogroup (B). There currently is not a meningococcal vaccine that offers protection against all common serogroups in one shot. Q: Can my child receive a quadrivalent meningococcal conjugate vaccine and a serogroup B meningococcal vaccine at the same time? A: Yes. Quadrivalent meningococcal conjugate and serogroup B meningococcal vaccines can be given during the same visit, but preferably in different arms. A serogroup B meningococcal vaccine is not recommended until age 1. National Meningococcal C Vaccination ProgramsTop of Page. Quadrivalent Meningococcal Conjugate Vaccines. Q: Why is a booster shot of a quadrivalent meningococcal conjugate vaccine recommended for my teen? A: Protection from a single dose of quadrivalent meningococcal conjugate vaccination declines in most teens within 5 years. So, a second dose is needed at age 1. Teens who receive their first dose of a quadrivalent meningococcal conjugate vaccine at or after age 1. Q: How soon after getting the first dose of a quadrivalent meningococcal conjugate vaccine can my child get the booster dose? A: The minimum time needed between doses is 8 weeks. However, the second dose is recommended at age 1. Q: How safe are quadrivalent meningococcal conjugate vaccines and what side effects are common? A: These vaccines are very safe. Vaccine safety will continue to be monitored. About half of the people who get a quadrivalent meningococcal conjugate vaccine have mild problems following vaccination, such as redness or pain where the shot was given or a mild fever. Developed to help understand what meningococcal disease is, why it is so dangerous, and how the meningitis vaccine can protect those at risk. Meningococcal vaccination for preteens and teens: Questions and answers for parents. CDC recommends permissive use of meningococcal serogroup B vaccine for ages 16-23, with a preferred age of 16-18. This recommendation joins the long-standing recommendation that all adolescents get meningococcal A, C, W and Y. These reactions usually get better on their own within 1 to 2 days, but serious reactions are possible. For more information, view the Meningococcal ACWY Vaccine Information Statement. Q: Does it matter which brand of quadrivalent meningococcal conjugate vaccine my child receives? A: No. There is no preference as to which brand (Menactra. However, it is preferred that the same vaccine brand be used for both doses. Top of Page. Serogroup B Meningococcal Vaccines. Q: When will serogroup B meningococcal vaccines be available and where can I find them? A: Your child's doctor may already have this vaccine in their office. However, since these are new vaccines and new guidelines, it may take some time for doctors to start stocking serogroup B meningococcal vaccines. College health centers or pharmacies may have them available. You can locate vaccine providers who carry serogroup B meningococcal vaccines by using the Health. Map Vaccine Finder. Q: Why does CDC not routinely recommend a serogroup B meningococcal vaccine for teens and young adults? If you're interested in having your child vaccinated with a serogroup B meningococcal vaccine, talk to your child. Outbreaks have recently occurred at several U. S. In response to the urgent need to control outbreaks of serogroup B meningococcal disease, serogroup B meningococcal vaccines were licensed by the Food and Drug Administration through an accelerated process. This means that a lot of data that officials typically have when making vaccine recommendations are not available right now for these vaccines. Available data suggest these vaccines are safe and CDC wants people to have access to them now to help prevent this uncommon, but serious illness. The current recommendation provides access and allows clinicians and parents to weigh the risk of the disease and the risks and benefits of vaccination. The Advisory Committee on Immunization Practices and CDC will continue to review data. Q: Are serogroup B meningococcal vaccines safe and what side effects are common? A: Available data suggest that serogroup B meningococcal vaccines are safe. Safety will continue to be monitored. More than half of the people who get a serogroup B meningococcal vaccine have mild problems following vaccination: Soreness, redness, or swelling where the shot was given. Tiredness (fatigue)Headache. Muscle or joint pain. Fever or chills. Nausea or diarrhea. These reactions usually get better on their own within 3 to 7 days, but serious reactions are possible. Serogroup B meningococcal vaccines are more likely to produce common or expected short- term side effects (especially pain where the shot was given) than other adolescent vaccines (i. HPV, quadrivalent meningococcal conjugate, and Tdap vaccine). For more information, view the Serogroup B Meningococcal Vaccine Information Statement. Q: Will insurance pay for serogroup B meningococcal vaccination for my child? A: Most health plans must cover a set of preventive services, including vaccines recommended on the CDC immunization schedules, with no out- of- pocket costs when provided by an in- network healthcare provider. Health plans are required to cover new vaccine recommendations without cost- sharing in the next plan year that occurs one year after the effective date of the recommendation, which is the date of publication in CDC's Morbidity and Mortality Weekly Report (MMWR). On October 2. 3, 2. MMWR for serogroup B meningococcal vaccination of 1. The recommendation to administer serogroup B meningococcal vaccine to people 1. B meningococcal disease outbreak was published in the MMWR on June 1. Patients should check with their insurance provider for details on whether there is any cost to them for this vaccine. The Vaccines for Children, or VFC, program provides vaccines for children 1. Medicaid- eligible, or American Indian or Alaska Native. Parents can find a VFC provider by contacting their local health department. VFC will cover the cost of serogroup B meningococcalvaccination for those. B meningococcal disease outbreak. Q: Does it matter which brand of a serogroup B meningococcal vaccine my child receives? A: No. CDC has no preference as to which brand (Bexsero. Multiple (2 or 3) doses are needed regardless of the brand chosen, and the same vaccine brand must be used for all doses. Q: Does my child need to finish the serogroup B meningococcal vaccine series? A: Yes. Both serogroup B meningococcal vaccines require more than one dose for maximum protection.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
January 2017
Categories |